Abstract
We report an unusual case of bilateral, synchronous breast cancer in a male patient who had a history of estrogen therapy for prostate cancer. A 64-year-old Japanese man was diagnosed with T1N0M0 prostate cancer and received a total prostatectomy. Twenty months after the resection, the patient developed multiple bone metastases, and received radiation therapy, systemic chemotherapy, and hormone therapy for 15 months. After completing this treatment, he was diagnosed with T1N0M0 primary breast cancer in his left breast and underwent a modified mastectomy. Five months after the mastectomy he received systemic chemotherapy followed by estrogen therapy because of the progression of prostate cancer. Three months after this treatment, he was diagnosed with T1N0M0 primary breast cancer in his right breast. To the best of our knowledge, this is a rare case of synchronous bilateral male breast cancer following hormone therapy for prostate cancer.
Similar content being viewed by others
References
Weiss JR, Moysich KB, Swede H (2005) Epidemiology of male breast cancer. Cancer Epidemiol Bilmarkers Prev 14:20–26
Narod SA, Offit K (2005) Prevention and management of hereditary breast cancer. J Clin Oncol 23:1656–1663
Cutuli BF (2007) Strategies in treating male breast cancer. Expert Opin Pharmacother 8:193–202
Swedlow AJ, Shoemaker MJ, Higgins CD, et al. (2005) Cancer incidence and mortality in men with Klinefelter syndrome: a cohort study. J Natl Cancer Inst 97:1204–1210
Tischkowitz MD, Hodgson SV, Fentiman IS (2002) Male breast cancer: etiology, genetics and clinical management. Int J Clin Pract 56:750–754
Levi F, Lucchini F, Vecchia CL (2002) Epidemiology of male breast cancer. Eur J Cancer Prev 11:315–318
Giordano SH, Buzdar AU, Hortobagyi GN (2002) Breast cancer in men. Ann Int Med 137:678–687
El-Gazayerli MM, Abdel-Aziz AS (1963) On bilateral and male breast cancer in Egypt: a preliminary report and review of literature. Br J Cancer 17:566–571
Olsson H, Ranstam J (1988) Head trauma and exposure to prolactin-elevating drugs as risk factors for male breast cancer. J Natl Cancer Inst 80:679–683
Karamanakos P, Apostolopoulos V, Fafauliotis S, et al. (1996) Synchronous bilateral primary male breast carcinoma with hyperprolactinoma. Acta Oncol 35:757–759.
Volm MD, Talamanti MS, Thangavelu M, et al. (1997) Pituitary adenoma and bilateral male breast cancer: an unusual association. J Surg Oncol 64:74–78
Hsing AW, Chakkalingam AP (2006) Prostate cancer epidemiology. Front Biosci 11:1388–1413
Fetiman IS, Fourquet A, Hortobagyi GN (2006) Male breast cancer. Lancet 367:595–604
Valeri A, Fournier G, Morin B, et al. (2000) Early onset and familial predisposition to prostate cancer significantly enhance the probability for breast cancer in first degree relatives. Int J Cancer 86:883–887
Stratton MR, Ford D, Neuhausen S, et al. (1994) Familial breast cancer is not linked to the BRCA1 locus on chromosome 17q. Nat Genet 7:103–107
Aarason A, Barkardottir RB, Egilsson V (1993) Linkage analysis of chromosome 17q markers and breast-ovarian cancer in Icelandic families, and possible relationship to prostatic cancer. Am J Hum Genet 52:711–719
Simpson E, Rubin G, Clyne C, et al. (1999) Local estrogen biosynthesis in males and females. Endocr Relat Cancer 6:131–137
Labrie F, Luu-The V, Lin SX, et al. (2000) Intracrinology: role of the family of 17 beta-hydroxysteroid dehydrogenases in human physiology and diseases. J Mol Endocrinol 25:1–16
Mahler C, Berhelst J, Denis L (1998) Clinical pharmacokinetics of the antiandrogens and their efficacy in prostate cancer. Clin Pharmacokinet 34:405–417
Potosky AL, Knopf K, Clegg LX, et al. (2001) Quality-of-life outcomes after primary androgen deprivation therapy: results from the prostate cancer outcomes study. J Clin Oncol 19:3750–3757
Kolvenbag GJ, Iversen P, Newling DW (2001) Antiandgrogen monotherapy: a new form of treatment for patients with prostate cancer. Urology 58:16–23
Sobin LH, Sherif M (1980) Relation between male breast cancer and prostate cancer. Br J Cancer 42:787–790
Schoenenberg BS (1977) Multiple primary malignancies. The Connecticut experience, 1935–1964. Recent results Cancer Res 58:1–173
Tellenberg C, Malmer B, Wiklund F, Gronberg H (2006) Breast cancer as a second primary in patients with prostate cancer — estrogen treatment or association with family history of cancer? J Urol 176:538–543
Symmers W (1968) Carcinoma of breast in transsexual individuals after surgical and hormonal interference with primary and secondary sex characteristics. BMJ 2:83–85
Pritchard TJ, Pankowsky DA, Crowe JP, et al. (1988) Breast cancer in a male to female transsexual. JAMA 259:2278–2280
Bounds WE, Burton GV, Schwalke MA (1993) Male breast cancer. J La State Med Soc 145:353–356
Coard K, McCartney T (2004) Bilateral synchronous carcinoma of the male breast in a patient receiving estrogen therapy for carcinoma of the prostate: cause or coincidence? Southern Med J 97:308–310
Howard RR, Grosjean WA, Kan W (1949) Bilateral mammary carcinoma in the male coincident with prolonged stilbestrol therapy. Surgery 25:300–303
McClure JA, Higgins CC (1951) Bilateral carcinoma of male breast after estrogen therapy. JAMA 146:7–9
Emoto A, Nasu N, Mimata H, et al. (2001) A male case of primary bilateral breast cancers during estrogen therapy for prostate cancer (in Japanese). Nippon Hinyokika Gakkai Zasshi 92:698–701
Staerkle RF, Lenzlinger PM, Suter SL, et al. (2006) Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. Breast Cancer Res Treat 97:173–176
Katz RL, Raval P, Brooks TE, Ordonez NG (1985) Role of immunocytochemistry in diagnosis of prostatic neoplasia by fine-needle aspiration biopsy. Diagn Cytopathol 1:28–32
Yu H, Diamandis EP, Sutherland DJA (1994) Immunoreactive prostate specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 27:75–79
Author information
Authors and Affiliations
Corresponding author
About this article
Cite this article
Kijima, Y., Yoshinaka, H., Hirata, M. et al. Synchronous bilateral breast cancer in a male patient following hormone therapy for prostate cancer. Int J Clin Oncol 14, 249–253 (2009). https://doi.org/10.1007/s10147-008-0824-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10147-008-0824-9